Mitsubishi Tanabe Pharma Corporation (4508.T)
1,159JPY
1:00am EST
¥12 (+1.05%)
¥1,147
¥1,156
¥1,162
¥1,148
403,000
856,100
¥1,372
¥926
4508.T
About
Overall
| Beta: | 0.53 |
| Market Cap (Mil.): | ¥643,662.88 |
| Shares Outstanding (Mil.): | 561.17 |
| Annual Dividend: | -- |
| Yield (%): | -- |
Financials
| 4508.T | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 3.54 | 4.61 |
| EPS (TTM): | -- | -- | -- |
| ROI: | -- | 1.79 | 2.83 |
| ROE: | -- | 2.40 | 3.59 |
Mitsubishi Tanabe Pharma <4508.T>-6mth group
6 months ended 6 months ended Full year to Full year ended
Mitsubishi Tanabe Pharma <4508.T>-6-month group
CONSOLIDATED EARNINGS ESTIMATES (in billions of yen unless specified)
UPDATE 2-Vertex sells future payments, sees wider '09 loss
* To get $155 mln related to future telaprevir payments
Mitsubishi Chem to buy Mitsubishi Rayon: Nikkei
TOKYO (Reuters) - Mitsubishi Chemical Holdings , is in talks to buy smaller rival Mitsubishi Rayon for up to $2.1 billion, the Nikkei business daily reported, in a move that would help consolidate Japan's overcrowded chemicals sector.
UPDATE 4-Mitsubishi Chem to buy Mitsubishi Rayon -Nikkei
* Mitsubishi Chem says "won't deny" considering acquisition
Mitsubishi Tanabe Pharma <4508.T>-1qtr group
3 months ended 3 months ended 6 months to Year to
Mitsubishi Tanabe Pharma <4508.T>-2008/09 parent
Year ended Year ended Year to
Mitsubishi Tanabe Pharma <4508.T>-2008/09 group
Year ended Year ended Year to Six months to
今日の株価格付け一覧＝日興シティグループ証券（13日）
［東京 １３日 ロイター］ １３日の日興シティグループ証券による株価格付けは以下の通り。 -------------------------------------------------- 格上げ ：高島屋「２Ｍ」→「１Ｍ」 (目標株価６５０円→８６０円) -------------------------------------------------------------------------------- 据え置き：ソニーフィナンシャルホールディングス「１Ｈ」 (目標株価３６００００円)
Mitsubishi Tanabe shares dive on falsified drug data
TOKYO, March 25 (Reuters) - Shares of Japanese drugmaker Mitsubishi Tanabe Pharma Corp plunged 14 percent after the company said it would recall two blood products after finding allergy-test data on one of them had been falsified.
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
